Volume 9, Issue 33 (12-2018)                   NCMBJ 2018, 9(33): 79-86 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ezzatizadeh F, Sari S, Hesampour A. Quantitative investigation of miRNA-196a-2 expression level in ovarian cancer patient in compare with normal by real Time PCR. NCMBJ 2018; 9 (33) :79-86
URL: http://ncmbjpiau.ir/article-1-1162-en.html
Department of Molecular and cellular sciences, Faculty of advanced science & Technology, Tehran medical sciences, Islamic Azad university, Tehran, Iran
Abstract:   (4205 Views)
Aim and Background: Current studies emphasize the key role of some non-coding RNAs in regulating the severity of different diseases as well as early diagnosis of various cancers. The aim of this study is to investigate the relation of ovarian cancer with miR-196a-2 expression level.
Material and method: In this study the expression of miR-196a-2 in 50 ovarian cancer patients and 50 control tissue sample were quantitatively investigated with quantitative reverse transcription PCR (qRT-pc) technique. The GAPDH gene was used as internal control gene.                
Result: Assessment of quantitative comparison showed that the miR-196a-2 expression level increased significantly in ovarian cancer patient in compare with control population. Increased miR-196a-2 probably effect through inhibiting the activity of tumor suppressor genes.
Conclusion: Based on miR-196a-2 expression level variation in tissue samples and quantitative increment in ovarian patients. We consider that evaluation of miR-196a-2 expressing level could be important role in investigation of ovarian cancer patients and could be use as biomarker to screen and early diagnosis of ovarian cancer patients.
Full-Text [PDF 514 kb]   (2711 Downloads)    
Type of Study: Research Article | Subject: Cellular and molecular
Received: 2018/12/22 | Accepted: 2018/12/22 | Published: 2018/12/22

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | New Cellular and Molecular Biotechnology Journal

Designed & Developed by : Yektaweb